1177.HK
Price:
$5.1
Market Cap:
$78.36B
Sino Biopharmaceutical Limited, an investment holding company, operates as a research and development pharmaceutical conglomerate in the People’s Republic of China. It operates through three segments: Modernised Chinese Medicines and Chemical Medicines, Investment, and Others. The company offers oncology medicines, including anlotinib hydrochloride capsules under Focus V brand, penpulimab injection under Annike brand, efbemalenograstin alfa injection under Yilishu brand, benmelstobart injection under Andewei brand, unecritinib fumarate capsules under Anboni brand, envonalkib citrate capsule under Anluoqing brand, garsorasib tablets under Anfangning brand, bevacizumab injection under Anbeisi ...[Read more]
Industry
Medical - Pharmaceuticals
IPO Date
2004-05-12
Stock Exchange
HKSE
Ticker
1177.HK
Dividends are a key part of long-term returns for investors, and Sino Biopharmaceutical Limited (1177.HK) has a track record worth reviewing. Looking at dividend history for 1177.HK gives you an idea of how consistent the dividends have been and what you might expect in the future.
Ex-Dividend Date
2026-06-24
Dividend Yield
1.96%
Annual Dividend
$0.05
P/E Ratio
15.32
Payout Ratio
0.64
Dividend per Share
$0.09
EPS
0.33
| Ex-Date/EFF Date | Dividend Amount | Adjusted Dividend | Payment Date | Declaration Date |
|---|---|---|---|---|
| 2026-06-24 | $0.05 | $0.05 | 2026-07-20 | |
| 2025-08-29 | $0.05 | $0.05 | 2025-09-23 | |
| 2025-06-16 | $0.04 | $0.04 | 2025-07-10 | |
| 2024-09-10 | $0.03 | $0.03 | 2024-10-04 | |
| 2024-06-11 | $0.03 | $0.03 | 2024-07-05 | |
| 2023-10-04 | $0.02 | $0.02 | 2023-10-27 | |
| 2023-06-20 | $0.06 | $0.06 | 2023-07-17 | |
| 2022-09-06 | $0.06 | $0.06 | 2022-09-28 | |
| 2022-06-15 | $0.04 | $0.04 | 2022-07-12 | |
| 2021-09-13 | $0.02 | $0.02 | 2021-10-04 | |
| 2021-06-18 | $0.02 | $0.02 | 2021-07-12 |
The table below shows Sino Biopharmaceutical Limited (1177.HK) dividend history over the years, including the amount per share, the payout date, and any adjustments for stock splits.
Sino Biopharmaceutical Limited (1177.HK) dividend history also allows you to track its dividend growth over time. This gives you insight into how the company’s earnings and payout ratios have evolved. Tracking this growth can help you gauge the stock's potential for future income.
Check out the dividend history of other popular stocks:
Tracking and finding valuable dividend stocks to invest in is difficult. For this, you can use Wisesheets, which allows you to pull all necessary dividend, financial, and price data to track your dividend investments in one place exactly how you want, using the power of spreadsheets.
You can build any custom analysis dashboards, screeners and trackers with no code and analyze companies like Sino Biopharmaceutical Limited (1177.HK) without the pain and hassle of copy pasting data.
What is dividend history?
How do I check past dividend history?
What does the ex-dividend date mean?
What is 1177.HK’s dividend yield?
What is the difference between regular and special dividends?
Has 1177.HK increased its dividends over time?
Why might dividend history data be delayed?
How often does 1177.HK pay dividends?
What factors impact 1177.HK's dividend payments?
Can dividends change over time?
What is 1177.HK’s next dividend date?